# Aligos Therapeutics, Inc.: Form 8-K, filed Oct 20, 2020

- Company: [Aligos Therapeutics, Inc.](/companies/algs.md) (CIK 1799448)
- Form: 8-K
- Filed: 2020-10-20
- Accepted by EDGAR: Oct 20, 2020, 16:03 ET
- Period: 2020-10-20
- Accession: 0001193125-20-272852
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1799448/000119312520272852/d46540d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799448/000119312520272852/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799448/000119312520272852/d46540d8k.htm

Filed Oct 20, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-272852. Last ingested by Listed: Nov 6, 2026, 12:13 ET. No prices; not investment advice.